The Journal of Immunology, Vol 151, Issue 10 5856-5863, Copyright © 1993 by American Association of Immunologists

ARTICLES

Characterization of type I complement C2 deficiency MHC haplotypes. Strong conservation of the complotype/HLA-B-region and absence of disease association due to linked class II genes

L Truedsson, CA Alper, ZL Awdeh, P Johansen, AG Sjoholm and G Sturfelt
Department of Medical Microbiology, Lund University, Sweden.

Fourteen individuals with complete C2 deficiency from 11 families and 3 heterozygous C2-deficient individuals from two families were investigated. In all the 24 independent C2-deficient haplotypes, the complotype S042 was present and the majority (21/24) was [HLA- B18,S042,DR2]. All carried the type I C2 deficiency C2 pseudogene with its characteristic 28 bp deletion. All but two haplotypes had 10 AC/GT repeats in the TNF alpha microsatellite polymorphism and all but one of the haplotypes were identical at or near HLA-B as assessed by RFLP using BstEII digestion and two genomic probes, R5A and M20A, located 100 and 38 kb centromeric to HLA-B, respectively. The exceptional haplotype was HLA-B40 with four AC/GT repeats at TNF-alpha. Three of the haplotypes were not DR2 based on generic and sequence-specific oligonucleotide typing. Another four haplotypes showed different DO- variants detected by RFLP analysis using BglIIand Mspl digestion. Thus, the [HLA-B18,S042,DR2] haplotype appears to be more fixed in the region between the complement genes and the HLA-B locus (96%) than in the region between the complement genes and DR (88%) and DO loci (71%). Of the 14 individuals studied, six had SLE or SLE-like syndromes and six had a history of severe infections although two were apparently healthy. Three of the six SLE patients and two individuals with repeated infections were homozygous for [HLA-B18,S042,DR2] and also homozygous for DQB1*0602 and the common DO variant. Thus, MHC class II genes linked to the C2 pseudogene do not appear to determine different clinical consequences of C2 deficiency.

This article has been cited by other articles:

				G. Jonsson, A. G. Sjoholm, L. Truedsson, A. A. Bengtsson, J. H. Braconier, and G. Sturfelt Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency Rheumatology, July 1, 2007; 46(7): 1133 - 1139. [Abstract] [Full Text] [PDF]

				D. M. Lipsker, C. Schreckenberg-Gilliot, B. Uring-Lambert, A. Meyer, D. Hartmann, E. M. Grosshans, and G. Hauptmann Lupus Erythematosus Associated With Genetically Determined Deficiency of the Second Component of the Complement Arch Dermatol, December 1, 2000; 136(12): 1508 - 1514. [Abstract] [Full Text] [PDF]

				R. A. Wetsel, J. Kulics, M.-L. Lokki, P. Kiepiela, H. Akama, C. A. C. Johnson, P. Densen, and H. R. Colten Type II Human Complement C2 Deficiency J. Biol. Chem., March 8, 1996; 271(10): 5824 - 5831. [Abstract] [Full Text] [PDF]

				R. Janulczyk, F. Iannelli, A. G. Sjoholm, G. Pozzi, and L. Bjorck Hic, a Novel Surface Protein of Streptococcus pneumoniae That Interferes with Complement Function J. Biol. Chem., November 17, 2000; 275(47): 37257 - 37263. [Abstract] [Full Text] [PDF]